toralizumab idec humanized monoclonal antibody immunosuppressive drug possible indications included treatment antibodymediated disorders immune thrombocytopenic purpura lupus nephritis rheumatoid arthritis tcellmediated diseases multiple sclerosis crohns disease transplantations solid organ transplantation pancreatic islet cell transplantation corneal transplantation bcell malignancies cllsmall lymphocytic lymphoma follicular cell lymphoma grade ii marginal zone lymphoma mantle cell lymphoma malt lymphoma waldenstr√∂ms macroglobulinemia monocytoid bcell lymphoma relapsedrefractory hodgkins phase ii clinical trials regarding multiple sclerosis crohns disease thromboembolisms occurred least three patients causal connection could proven since adverse effects seen trials similar antibody trials drug developed idec pharmaceuticals corporation immune activation dostarlimab ibalizumab monoclonal article stub help wikipedia expanding antineoplastic immunomodulatory drug article stub help wikipedia expanding httpsenwikipediaorgwikitoralizumab